Torrent Net Income from 2010 to 2024

TORNTPHARM   3,324  121.25  3.79%   
Torrent Pharmaceuticals' Net Income is increasing with slightly volatile movements from year to year. Net Income is estimated to finish at about 17.4 B this year. For the period between 2010 and 2024, Torrent Pharmaceuticals, Net Income quarterly trend regression had mean deviation of  4,274,051,573 and range of 16.9 B. View All Fundamentals
 
Net Income  
First Reported
2011-12-31
Previous Quarter
4.6 B
Current Value
4.5 B
Quarterly Volatility
1.4 B
 
Yuan Drop
 
Covid
Check Torrent Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Torrent Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.4 B, Interest Expense of 1.8 B or Selling General Administrative of 4.4 B, as well as many indicators such as . Torrent financial statements analysis is a perfect complement when working with Torrent Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Torrent Pharmaceuticals Technical models . Check out the analysis of Torrent Pharmaceuticals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Torrent Stock

Torrent Pharmaceuticals financial ratios help investors to determine whether Torrent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Torrent with respect to the benefits of owning Torrent Pharmaceuticals security.